Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 4/20 | 0.69 |
| ▸ | HTR1A | P08908 | 2/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | HTT | P42858 | 1/20 | 0.69 |
| ▸ | MC5R | P33032 | 1/20 | 0.62 |
| ▸ | MC3R | P41968 | 1/20 | 0.62 |
| ▸ | MC1R | Q01726 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | G6PD | P11413 | 1/20 | 0.57 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.56 |
| ▸ | IDO1 | P14902 | 1/20 | 0.56 |
| ▸ | HTR2C | P28335 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5833228 | 0.98 | HTR2A (0.67) | HTR2AHTR1AKDM4EALDH1A1HTT | |
| Methyl Carbamate SCHEMBL6828080 | 0.90 | MEN1 (0.61) | HTR2AHTR1AKDM4EALDH1A1HTT | |
| SCHEMBL27174179 | 0.84 | HTR2A (0.66) | HTR2AHTR1AKDM4EALDH1A1HTT | |
| SCHEMBL28242499 | 0.84 | HTR2A (0.64) | HTR2AHTR1AKDM4EALDH1A1HTT | |
| SCHEMBL29385251 | 0.81 | HTR2A (1.00) | HTR2AHTR1AKDM4EALDH1A1HTT | |
| SCHEMBL379409 | 0.81 | HTR2A (1.00) | HTR2AHTR1AKDM4EALDH1A1HTT | |
| SCHEMBL21333616 | 0.81 | HTR2A (0.60) | HTR2AHTR1AKDM4EALDH1A1HTT | |
| SCHEMBL17232881 | 0.81 | MC5R (0.83) | HTR2AHTR1AKDM4EALDH1A1HTT | |
| SCHEMBL9559245 | 0.81 | MEN1 (0.68) | HTR2AHTR1AKDM4EALDH1A1HTT | |
| SCHEMBL3241386 | 0.80 | HTR2A (0.68) | HTR2AHTR1AKDM4EALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118291286-A | Yarrowia lipolytica engineering bacterium for synthesizing N-acetyl-5 methoxy tryptamine by taking tryptophan as substrate, construction and application thereof | 河北维达康生物科技有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118020575-A | Planting method of traditional Chinese medicine baical skullcap root in saline-alkali soil | 中国科学院遗传与发育生物学研究所农业资源研究中心 | 2024-05-14 | — | — | CN | claimed |
| CN-117625517-A | Zebra fish embryo culture solution for detecting efficacy of cosmetics and application thereof | 福建中妆技术研究有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117343854-A | Yarrowia lipolytica engineering bacterium for synthesizing N-acetyl-5 methoxy tryptamine by using 5-hydroxytryptophan as substrate and application thereof | 河北维达康生物科技有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-115364283-A | Bionic interface multilayer composite nerve scaffold and preparation method and application thereof | 上海市第六人民医院 | 2022-11-22 | — | — | CN | claimed |
| CN-112195151-B | Dental pulp mesenchymal stem cell recovery culture solution, preparation method and recovery culture method | 范德里希(上海)生物科技有限公司 | 2022-06-21 | — | — | CN | claimed |
| EP-4003274-A1 | COSMETIC COMPOSITIONS COMPRISING PLANT EXTRACTS AND USES THEREOF | Alumier Europe Limited (MT) | 2022-06-01 | — | — | EP | claimed |
| WO-2021013973-A1 | COSMETIC COMPOSITIONS COMPRISING PLANT EXTRACTS AND USES THEREOF | ALUMIER EUROPE LIMITED (MT) | 2021-01-28 | — | — | WO | claimed |
| CN-112195151-A | Dental pulp mesenchymal stem cell recovery culture solution, preparation method and recovery culture method | 夏爽 | 2021-01-08 | — | — | CN | claimed |
| CN-106317187-B | Five methoxytryptamine base carbonyl propionyl-PAK peptides, preparation, activity and application | 首都医科大学 | 2019-07-12 | — | — | CN | claimed |
| EP-1476152-A4 | USE OF MELATONIN ANALOGUES FOR INDUCTION OF GENERAL ANESTHESIA | UNIV IOWA RES FOUND (US) | 2007-04-11 | — | — | EP | claimed |
| CN-1708331-A | Preparation containing melatonin, semen Ginkgo and biotin | ASAT AG APPLIED SCIENCE & TECH (CH) | 2005-12-14 | — | — | CN | claimed |
| EP-1476152-A2 | USE OF MELATONIN ANALOGUES FOR INDUCTION OF GENERAL ANESTHESIA | University of Iowa Research Foundation (US) | 2004-11-17 | — | — | EP | claimed |
| US-20040022822-A1 | Cosmetic compositions containing keratinization modulators and methods for improving keratinous surfaces | REVLON CONSUMER PRODUCTS CORPORATION (US) | 2004-02-05 | — | — | US | claimed |
| WO-2003070177-A2 | USE OF MELATONIN ANALOGUES FOR INDUCTION OF GENERAL ANESTHESIA | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2003-08-28 | — | — | WO | claimed |
| EP-1212056-A1 | METHODS AND COMPOSITIONS FOR BISUBSTRATE INHIBITORS OF ACETYLTRANSFERASES | The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2002-06-12 | — | — | EP | claimed |
| US-20020034524-A1 | Cosmetic compositions containing keratinization modulators and methods for improving keratinous surfaces | REVLON CONSUMER PRODUCTS CORPORATION | 2002-03-21 | — | — | US | claimed |
| WO-2002000176-A1 | COSMETIC COMPOSITIONS CONTAINING KERATINIZATION MODULATORS AND METHODS FOR IMPROVING KERATINOUS SURFACES | REVLON CONSUMER PRODUCTS CORPORATION (US) | 2002-01-03 | — | — | WO | claimed |
| WO-2001012185-A1 | METHODS AND COMPOSITIONS FOR BISUBSTRATE INHIBITORS OF ACETYLTRANSFERASES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2001-02-22 | — | — | WO | claimed |
| US-4428880-A | Azepino[4,5-d]indole derivatives and preparation thereof | S.A. OMNICHEM (BE) | 1984-01-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020034524-A1 | Cosmetic compositions containing keratinization modulators and methods for improving keratinous surfaces | KRT18, MC1R, HTR6 | HTR2A 7/4885HTR1A 14/4885KDM4E 1494/4885 |
| US-20040022822-A1 | Cosmetic compositions containing keratinization modulators and methods for improving keratinous surfaces | KRT18, MC1R, HTR6 | HTR2A 7/4885HTR1A 14/4885KDM4E 1494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.